- Filed
- May 6, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Apr 25, 2025 | 262.07M sh |
| Current Liabilities | Q2 2025 · Mar 28, 2025 | $3.18B |
| Current Liabilities | Q2 2025 · Sep 27, 2024 | $4.21B |
| Current Assets | Q2 2025 · Mar 28, 2025 | $3.84B |
| Current Assets | Q2 2025 · Sep 27, 2024 | $3.41B |
| Total Assets | Q2 2025 · Mar 28, 2025 | $13.49B |
| Total Assets | Q2 2025 · Sep 27, 2024 | $12.67B |
| Cash And Equivalents | Q2 2025 · Sep 27, 2024 | $672.48M |
| Cash And Equivalents | Q2 2025 · Mar 29, 2024 | $356.61M |
| Shares Diluted | Q2 2025 · Mar 29, 2024 | 265.28M sh |
| Shares Diluted | Q2 2025 · Mar 29, 2024 | 264.78M sh |
| Stock Repurchased | Q2 2025 · Mar 29, 2024 | $0 |
| Dividends Paid | Q2 2025 · Mar 29, 2024 | $49.86M |
| Capex | Q2 2025 · Mar 29, 2024 | $203.03M |
| Operating Cash Flow | Q2 2025 · Mar 29, 2024 | −$435.8M |
| Stockholders Equity | Q2 2025 · Mar 29, 2024 | $2.89B |
| Stockholders Equity | Q2 2025 · Dec 29, 2023 | $2.85B |
| Stockholders Equity | Q2 2025 · Sep 29, 2023 | $3.71B |
| Eps Diluted | Q2 2025 · Mar 29, 2024 | $0.20 |
| Eps Diluted | Q2 2025 · Mar 29, 2024 | $0.31 |
| Eps Basic | Q2 2025 · Mar 29, 2024 | $0.20 |
| Eps Basic | Q2 2025 · Mar 29, 2024 | $0.31 |
| Sga Expense | Q2 2025 · Mar 29, 2024 | $62.56M |
| Sga Expense | Q2 2025 · Mar 29, 2024 | $152.75M |
| Net Income | Q2 2025 · Mar 29, 2024 | $53.45M |
| Net Income | Q2 2025 · Mar 29, 2024 | $81.99M |
| Net Income | Q2 2025 · Dec 29, 2023 | $28.54M |
| Operating Income | Q2 2025 · Mar 29, 2024 | $159.09M |
| Operating Income | Q2 2025 · Mar 29, 2024 | $326.04M |